摘要
目的:调查多囊卵巢综合征(PCOS)中非酒精性脂肪肝(NAFLD)的发病情况并对相关危险因素做出分析。方法:将本院2001年2月~2010年3月收治的142例PCOS患者按照B超诊断分为两组,非NAFLD组92例,NAFLD组50例,比较两组之间BMI、To、FINS、2hINS、Homa-IR、CHO、ALT、AST等生化、代谢指标。结果:142例PCOS患者经B超诊断,NAFLD的发生率为36.62%(52/142);PCOS患者中已婚患者的NAFLD发病率(37.50%)与未婚患者的NAFLD发病率(33.33%)之间差异无统计学意义(P〉0.05);肥胖PCOS患者中NAFLD的发病率(66.07%)明显高于非肥胖NAFLD的发病率(17.44%),且差异有统计学意义(P〈0.05);NAFLD组上述各项生化、代谢指标均大于非NAFLD组,且差异均有统计学意义(P〈0.05)。结论:控制体重、适量运动、低脂饮食、改善胰岛素抵抗、早期检测和干预是防止PCOS患者中NAFLD发生的重要措施。
Objective:To investigate the incidence of non-alcoholic fatty liver disease(NAFLD) with polycystic ovary syndrome(PCOS) and to analyze the related risk factors.Methods:142 PCOS patients were divided into two groups according to the B ultrasonic diagnosis,92 cases in non-NAFLD group and 50 cases in NAFLD group.Compare the indicators such as BMI,To,FINS,2hINS,HomaIR,CHO,ALT and AST.Results:In 142 patients with PCOS,the incidence rate of NAFLD was 36.62%(52 /142);there were no statistical differences between the incidence of married patients with NAFLD(37.50%) and unmarried patients with NAFLD(33.33%)(P0.05);the incidence of NAFLD in obese PCOS patients(66.07%) was significantly higher than the incidence of NAFLD in non-obese(17.44%),and the difference was statistically significant(P0.05);of NAFLD group the various biochemical,metabolic indicators were greater than the nonNAFLD group,and the differences were statistically significant(P0.05).Conclusion:weight control,regular exercise,low-fat diet,improving insulin resistance,early detection and intervention are important measures to prevent NAFLD occurring in patients with PCOS.
出处
《中国医药导刊》
2013年第1期37-38,共2页
Chinese Journal of Medicinal Guide